Objective: To describe a case of juvenile angiofibroma with unusual protrusion out of the nasal cavity, and its management with surgery and radiotherapy.
CASE REPORT
A 17-year-old Sabahan man presented with a one-year history of left nasal obstruction with recurrent epistaxis. Examination revealed a brownish well defined mass measuring 6x5 cm protruding from his left nostril (Figure 1 ). The rest of the physical examination was noncontributory.
Contrast-enhanced computed tomography (CT) scan showed a heterogenous mass occupying the left pterygopalatine fossa with anterior extension through the left nasal cavity protruding through the nose, lateral extension to the left infratemporal fossa, superior extension to the left ethmoidal and sphenoidal sinuses as well as the posterior part of the left orbit. (Figure 2 ) Magnetic resonance imaging (MRI) further characterized the tumor as an enhancing mass with small intracranial extension to left middle cranial fossa and dural involvement. (Figure 3 ) The radiographic features were suggestive of JA.
Angiography of both internal (ICA) and external carotid artery (ECA) revealed the tumor supplied by branches of both ICA and maxillary arteries from both ECA. Seventy percent (70%) of the tumor-feeding vessels were successfully embolized. Figure 4A and B shows the arteriogram before and after embolization.
The definitive surgical procedure was performed the next day. The external nasal mass was first ligated and truncated from the nose. The internal portion of the tumor was resected via a Weber Ferguson 
DISCUSSION
The diagnosis of JA was almost certain in view of the patient's gender, age and clinical presentation. A tumor protruding from the nasal cavity can be very tempting for a tissue biopsy, but doing so in an unprepared circumstance could spell disaster. The diagnosis could have been easily missed were it not for the initial evaluation with imaging studies because JA does not usually present as a mass protruding from the nose. Angiography further established the diagnosis and allowed embolization to be done in the same setting, The Fisch 6 classification (Table 1 ) has been commonly used for staging the disease. There are three other commonly employed staging systems (Table 2) . [7] [8] [9] None of these classifications mention tumor extension out of the nostril.
Staging is important to the surgeon to predict the outcome, to ascertain the chance of complete excision as well as to determine the approach to tumor resection. Not counting the extranasal tumor extension, the patient in this case was stage IIIA based on Radkowski classification. He underwent selective angiography to establish a definite diagnosis and to embolize the feeding vessels. This method has been widely recognized to reduce intraoperative blood loss which in turn facilitates the removal of tumor. 10 Ungkanont et al. reported in a study with 43 cases that morbidity, recurrence and intraoperative complications decreased with embolization. 11 However, there are several risks of embolization including bleeding, allergic reactions and strokes. The patient in this case was free from these complications.
There are several modalities of treatment for JA, with surgical resection and irradiation therapy being the most successful. It is generally accepted that surgery is the treatment of choice while radiotherapy is best for recurrence post surgery or extensive tumor with significant intracranial extension (where total resection with acceptable morbidity is unlikely). There is also a relatively large series of 55 patients with JA, where 42 underwent radiotherapy as the primary therapy and 80% were successfully treated. 12 Surgical resection was essential for the patient in this case because he had a huge tumor protruding from his nostril, which was unlikely to regress with other treatments. It is also generally accepted that external approaches are superior in advanced tumors. 13 In view of the tumor extent, the open approach was adopted. However, resection was incomplete due to intracranial extension. Hence, adjuvant radiotherapy was given for residual disease. Mendenhall et al. summarized six studies on the outcome of radiotherapy for JA. 5 Most patients in these series were those who exhibited recurrence after prior surgery or had intracranial extension. After completing radiotherapy, local control rates ranged from 73% to 100%. Almost all those with recurrence after radiotherapy were successfully treated with another surgery or a second course of radiotherapy. Hence, the ultimate local control was nearly 100%.
Our case shows that a high index of suspicion is of paramount importance in the diagnosis of JA and alleviates the possibility of an unwarranted biopsy, as an indiscriminate biopsy could spell disaster. The most useful tools are MRI and arterial angiography. Once the definite diagnosis is established, the treatment plan has to be mapped out which is primarily surgical. Irradiation therapy has been reported to achieve satisfactory outcome, especially for unresectable residual disease and/or intracranial extension, where total surgical resection is unlikely to be attained without unacceptable morbidity.
Stage Description
I Tumors limited to the nasal cavity nasopharynx with no bony destruction. II Tumors invading the pterygomaxillary fossa, paranasal sinuses with bony destruction. III Tumors invading the infratemporal fossa, orbit and parasellar region remaining lateral to the cavernous sinus.
IV
Tumors with invasion to the cavernous sinus, optic chiasmal region and pituitary fossa. 
